'Treatment alliance' needed to save more children's lives from cancer

October 8, 2012

Experts are calling for an urgent change to approaches for treating and researching childhood cancers, to continue to save more children from the disease.

Today nearly eight in 10 children diagnosed with cancer in Great Britain now survive for five years or more, compared with fewer than three out of 10 in the 1960s. This has been thanks to such as , but these improvements have plateaued in recent years.

A new 'treatment alliance' that will bring together researchers, , and patients and their parents will be discussed today (Saturday) at this year's SIOP conference, organised by the International Society for Paediatric Oncology. The conference brings together over 2,000 leading childhood cancer specialists from across the globe for a three day conference in London.

This 'alliance' will identify and focus efforts on the unmet needs of patients – from developing new and targeted treatments that directly benefits patients, ensuring patients have access to these latest treatments and giving companies incentives to develop new treatments.

Professor Kathy Pritchard-Jones, a childhood cancer specialist at University College London and Great Ormond Street Hospital, said: "Cancer in children is a very unique disease, with many treatments designed for adults not suitable. Saving more children's lives from the disease can only be achieved by collaborative research across continents, as more and more, new treatments are focused on small groups of patients based on the of the cancer.

"Only by bringing together this 'treatment alliance' can we make the next leap in saving more children from cancer. Only in this way will the needs of these children be met first."

The substantial improvements in survival after childhood cancer mean that there are around 26,000 people alive in Great Britain who have survived for five years or more, so the need to reduce the long-term side effects is hugely important for these survivors.

Professor Pritchard-Jones added:  "It's not just successfully treating the cancer that counts; our ultimate ambition is to maximise the chance of survival while minimising the side effects of treatment. This is what our patients demand of us and what we must strive to achieve. A cured survivor has 65-70 years ahead of them to achieve their full potential."

Kate Law, director of clinical research at Cancer Research UK, said: "We welcome this push to accelerate the development of new treatments for childhood cancers. The UK has been at the forefront of bringing new treatments to children with cancer and today thousands more children have survived the disease than would have done 30 years ago. Clinical trials are essential for making new treatments available to with cancer, and Cancer Research UK is campaigning to cut the red tape that's hindering clinical research across Europe, while maintaining a safe environment for ."  

Explore further: Access to clinical trials drives dramatic increases in survival from childhood cancer

Related Stories

Access to clinical trials drives dramatic increases in survival from childhood cancer

July 17, 2012
More children are surviving cancer in Britain than ever before according to new research published in the cancer journal Annals of Oncology [1] today (Wednesday). The improvement in survival has been driven by the increasing ...

Childhood cancer survivors at greater risk in middle age

June 6, 2011
Scientists at the University of Birmingham have found that survivors of childhood cancers are four times more likely than the general population to develop a new cancer. The results are published online today in the Journal ...

Cancer Research UK launches trial of new drug to treat acute childhood leukaemia

January 27, 2012
Cancer Research UK’s Drug Development Office has opened the first trial of a new type of drug to treat children aged from six months to 18 years with acute leukaemia, who are no longer responding to treatment.

Recommended for you

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Liquid biopsy results differed substantially between two providers

December 14, 2017
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

rwinners
not rated yet Oct 08, 2012
Today nearly eight in 10 children diagnosed with cancer in Great Britain now survive for five years or more, compared with fewer than three out of 10 in the 1960s."

A very shallow measure of success. How many of those 8 survive another 5 years? What is the quality of their lives during those years?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.